SMMT

Summit Therapeutics
SMMT

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$24.51B
EV
$24.11B
Shares Outstanding
796.87M
Beta
-0.46

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$35.48
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Summit Therapeutics Inc.

gainify
SMMT

Summit Therapeutics Inc.

SMMT

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the United States, and the United Kingdom. The company’s lead development can...

Sector

Healthcare

Industry

Biotechnology

CEO

Data Unavailable

Employees

159

IPO Date

2015-03-05

Headquarters

601 Brickell Key Drive, Suite 1000, Miami, Florida, 33131, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved